Systematic review / meta-analysis / 2014
Coffee consumption was associated with favorable liver enzymes and reduced risks of cirrhosis, mortality, and hepatocellular carcinoma.
A systematic review examined studies investigating the association of coffee consumption with liver-related laboratory tests, viral hepatitis, NAFLD, cirrhosis, and hepatocellular carcinoma (HCC). In people at risk for liver disease, coffee intake was dose-dependently associated with improved serum GGT, AST, and ALT values. In patients with chronic liver disease, coffee consumption was linked to a lower risk of progression to cirrhosis, reduced mortality in cirrhosis, and lower HCC development. Coffee was also linked to improved virologic responses in chronic hepatitis C and was inversely related to steatohepatitis severity in NAFLD.
Shows an association, not proof of cause and effect.
- Study type
- Systematic review
- Who was studied
- Individuals at risk for or with liver disease
- What was measured
- Liver enzymes, viral hepatitis, NAFLD, cirrhosis, and hepatocellular carcinoma
THE PAPER
Impact of coffee on liver diseases: a systematic review.
Saab S, Mallam D, Cox GA, Tong MJ. Liver Int, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.